A novel oncolytic herpes simplex virus armed with the carboxyl-terminus of murine MyD116 has enhanced anti-tumour efficacy against human breast cancer cells.
about
A novel oncolytic herpes simplex virus armed with the carboxyl-terminus of murine MyD116 has enhanced anti-tumour efficacy against human breast cancer cells.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh
2018年學術文章
@zh-hant
name
A novel oncolytic herpes simpl ...... nst human breast cancer cells.
@en
A novel oncolytic herpes simpl ...... nst human breast cancer cells.
@nl
type
label
A novel oncolytic herpes simpl ...... nst human breast cancer cells.
@en
A novel oncolytic herpes simpl ...... nst human breast cancer cells.
@nl
prefLabel
A novel oncolytic herpes simpl ...... nst human breast cancer cells.
@en
A novel oncolytic herpes simpl ...... nst human breast cancer cells.
@nl
P2093
P2860
P356
P1433
P1476
A novel oncolytic herpes simpl ...... nst human breast cancer cells.
@en
P2093
Jiani Wang
Jingjing Fan
Renbin Liu
P2860
P304
P356
10.3892/OL.2018.8247
P577
2018-03-13T00:00:00Z